Chronic Fatigue Syndrome Diagnostic Panel
The chronic fatigue syndrome (CFS) is a public health problem in the U.S. affecting young adults between ages 35-65 in a ratio of four females to one male. Although many different etiologies for CFS have been extensively investigated, the etiology of CFS still remains unknown. Some investigations attempted to show correlation with infectious agents that cause chronic infection such as Herpes viruses (EBV, CMV and HHV6), Borrelia burgdorferi, Babesia microti, Chlamydia species, Anaplasma phagocytophila and some other slowly developing infections. Other investigators sought to correlate CFS with an immunologic origin due to an autoimmune antibody, similar to an autoimmune disease. Another line of investigation attempted to correlate CFS with neurological disorders showing brain changes as a cause of disease. Some CFS patients show myocardial weakness with inverted and flat T waves, which likely contributes to fatigue and weakness.
The patient with CFS resembles the patient with infectious mononucleosis except that the CFS patient does not recover and does not have the physical findings of a patient with mononucleosis. The clinical similarities have suggested that the “mononucleosis syndrome” and “chronic fatigue syndrome” may share the same causal relationships. Symptoms of CFS are sudden onset of fatigue (often following an infection such as a cold or actual infectious mononucleosis), a feeling of feverishness without actual fever, sore throat, painful cervical and/or axillary lymph nodes (without lymphadenopathy), muscle fatigability without actual objective weakness or abnormal electromyogram, myalgias, arthralgias (but without redness, swelling or reduced range of motion), headaches, difficulty concentrating, psychiatric problems, allergies, depression and disturbances of sleep. Four of these symptoms, light-headedness, and chest ache with increasing fatigue particularly at the end of the day and not related to exertion, palpitations, and muscle ache can be used to follow a patient’s course. In almost all cases symptoms are worsened by any physical exertion and the need to lie supine (not necessarily to sleep) daily is universal. Symptoms are similar to fibromyalgia and myalgic encephalomyelitis, which may be part of a spectrum.
Diagnosis of CFS is one of exclusion and should be performed using a thorough physical examination and history, temperature and weight records and limited laboratory testing.
The panel includes these tests: CBC, AST, ALT, Creatinine, CRP, EST, ASO, Urinalysis, Lyme IgG and IgM, Lyme Western blot if Lyme ELISA positive, Babesiosis IgG and IgM, EBV IgM, EBV EA, CMV IgG and IgM, CMV p52 antigen, CMV p57 antigen (CM2), HHV6 and 24 hours holter monitor.
- Diagnosis of chronic fatigue syndrome
- As an aid in diagnosis of myalgic encephalomyelitis
- As an aid in diagnosis of fibromyalgia
- Disease management
- Rule out chronic fatigue syndrome
I. A diagnosis of EBV-subset CFS requires a positive from EBV(VCA) IgM AND/OR EBV,EA Diffuse PLUS flat or inverted T-waves present at rest or stress during Holter monitoring.
II. A diagnosis of CMV-subset CFS requires a positive from CMV(V)IgG, CMV(V)IgM, CMV p52 IgM, OR CMV CM2 IgM PLUS flat or inverted T-waves present at rest or stress during Holter monitoring.
III. A diagnosis of EBV,CMV-subset CFS requires BOTH criteria I and II as listed below.
If positive for any of the chronic infectious agents such as EBV, CMV and HHV6), infection with B. Burgdorferi*, Babesia microti*, Chlamydia*, Anaplasma phagocytophila or co-infection of more than one might indicate diagnostic of chronic fatigue syndrome. See interpretation below.
Chronic Fatigue Syndrome Diagnostic Panel
General Groups
| Name | Description | Results | Interpretation |
|---|---|---|---|
| CBC | Complete blood cell count | Normal | Monitors complete blood cell count during therapy (MCV often rises during therapy) |
| AST | Aspartate aminotransferase | Normal | Assess transferase activity of the liver |
| ALT | Alanine aminotransferase | Normal | Assess transferase activity of the liver |
| Creatinine | Serum creatinine level | Normal | Measure renal function |
| CRP | C-reactive protein | Negative | Identify the presence of inflammation |
| ESR | Erythrocyte sedimentation rate | Normal | Identify the presence of inflammation |
| ASO | Antistreptolysin O titer | Negative (less than 400 U) | Monitor past group A streptococcal infection |
| Urine Analysis | Complete urine analysis | Normal | Detect abnormalities in urine analysis |
Specific Groups
| Name | Description | Results | Interpretation |
|---|---|---|---|
| Lyme ELISA IgG / IgM | Anti–Borrelia burgdorferi serum antibody | Negative | Detects serum antibodies to bacterium causing Lyme disease |
| Lyme Western Blot IgG / IgM | CDC criteria for positive and negative test utilized | Negative in CFS | Confirmation of positive serology for antibody to Borrelia burgdorferi IgG or IgM by ELISA |
| Babesiosis ELISA IgG / IgM | Babesia microti serum antibody | Negative in CFS | Test is negative in CFS |
| EBV-VCA IgM | Serum antibody (IgM) to Epstein–Barr virus (EBV) viral capsid antigen (VCA) | Positive | Indicates current EBV infection |
| EBV-EA | Serum antibody to Epstein–Barr virus (EBV) Early Antigen (EA), diffuse | Positive | Indicates current EBV infection |
| CMV (V) IgG | Cytomegalovirus (CMV) IgG serum antibody to viral capsid antigen (VCA) | Positive | Indicates past infection with CMV |
| CMV (V) IgM | Cytomegalovirus (CMV) IgM antibody to viral capsid antigen (VCA) | Positive | Indicates current CMV infection |
Other finding
| Name | Description | Results | Interpretation |
|---|---|---|---|
| CMV-p52 IgM | CMV IgM serum antibody to p52 (UL44) gene product | Positive | Indicates current CMV infection |
| CMV-CM2 IgM | CMV IgM serum antibody to p52 (UL44) and p57 (UL57) gene products | Positive | Indicates current CMV infection |
| HHV-6 IgG / IgM | Antibody to Human Herpesvirus 6 (IgG and IgM) | Positive | Indicates HHV-6 infection |
Holter monitor, 24 hour:
| Name | Description / Findings | Results | Interpretation |
|---|---|---|---|
| 24-hour Electrocardiographic Monitor | Continuous ambulatory ECG monitoring | Flat or inverted T-wave patterns present at either rest or during stress-exercise | Detects cardiac involvement in CFS |
| ECG (Standard 12-lead Electrocardiogram) | Standard 12-lead electrocardiogram | Normal or minor T-wave changes | May show T-wave flattening in any lead or other minor abnormalities |
See individual tests.
See individual tests.
- Ann Intern Med. 1988;108:387-9. [PMID: 2829679]
- Ann Intern Med. 1994;121:953-959. [PMID: 7978722]
- Current Rheumatology Reports. 2007;9:482-487. [PMID: 18177602]
- Clin Diag Lab Immunol. 2005;12:1259-60. [PMID: 16210496]
- Science. 2009 Oct 23;326(5952):585-9. [PMID: 19815723].
- J Clin Pathol. 2008 May;61(5):623-6. [PMID: 18037660]
- In Vivo. 2002 May-Jun;16(3):153-9. [PMID: 12182109]
- Drugs Today (Barc). 2002 Aug;38(8):549-61. [PMID: 12582420]
- In Vivo. 2007 Sep-Oct;21(5):707-13. [PMID: 18019402]
- In Vivo. 2004;18:101-106. [PMID: 15113035]
- In Vivo. 2008 Nov-Dec;22(6):799-801. [PMID: 19181009]
- Clin Exp Rheumatol. 2013 Nov-Dec;31(6 Suppl 79):S153-7. [PMID: 24373373]
- J Am Osteopath Assoc. 2013 Sep;113(9):680-9. [PMID: 24005088]
- Harrison’s 16th Edition Principles of Internal Medicine. New York: McGraw-Hill; 2004: 2545-2547.